MMA
XYL icon

Miracle Mile Advisors’s Xylem XYL Stock Holding History

Miracle Mile Advisors’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
9,482
-22
-0.2% -$2.54K 0.01% 417
2026
Q1 		$1.14M Sell
9,504
-247
-3% -$32.4K 0.02% 400
2025
Q4 		$1.33M Buy
9,751
+52
+0.5% +$7.48K 0.02% 367
2025
Q3 		$1.43M Buy
9,699
+104
+1% +$14.4K 0.02% 346
2025
Q2 		$1.24M Buy
9,595
+282
+3% +$34.2K 0.02% 330
2025
Q1 		$1.11M Sell
9,313
-323
-3% -$40K 0.02% 305
2024
Q4 		$1.12M Buy
9,636
+1,658
+21% +$210K 0.02% 315
2024
Q3 		$1.08M Buy
7,978
+27
+0.3% +$3.61K 0.02% 266
2024
Q2 		$1.08M Sell
7,951
-5
-0.1% -$680 0.03% 246
2024
Q1 		$1.03M Buy
7,956
+15
+0.2% +$1.81K 0.03% 268
2023
Q4 		$908K Sell
7,941
-133
-2% -$13.3K 0.02% 276
2023
Q3 		$735K Hold
8,074
– – 0.02% 284
2023
Q2 		$909K Hold
8,074
– – 0.03% 269
2023
Q1 		$845K Sell
8,074
-150
-2% -$15.7K 0.03% 295
2022
Q4 		$909K Buy
8,224
+171
+2% +$17.9K 0.03% 282
2022
Q3 		$704K Buy
+8,053
New +$732K 0.03% 243

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Miracle Mile Advisors's XYL Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Xylem (XYL) stake by 0.23% in Q2 2026, selling an estimated $2.54K and leaving 9,482 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #417.

Miracle Mile Advisors first reported a position in XYL in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.43M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Miracle Mile Advisors held 9,482 shares of Xylem worth $1.12M as of Q2 2026.
  • Miracle Mile Advisors sold 22 Xylem shares in Q2 2026, an estimated $2.54K.
  • Xylem made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #417 holding.
  • Miracle Mile Advisors first reported a position in Xylem in Q3 2022 and has held it in 16 quarters since.
  • Miracle Mile Advisors's Xylem position peaked at $1.43M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.